Buys | $0 | 0 | 0 |
Sells | $8,063 | 2 | 100 |
Finger Michael H. | director | 0 | $0 | 2 | $8,063 | $-8,063 |
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Over the last 12 months, insiders at Creative Medical Technology Holdings, Inc. have bought $0 and sold $8,063 worth of Creative Medical Technology Holdings, Inc. stock.
On average, over the past 5 years, insiders at Creative Medical Technology Holdings, Inc. have bought $37,105 and sold $70,234 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 200 shares for transaction amount of $872 was made by Warbington Timothy (President & CEO) on 2023‑06‑28.
2025-02-19 | Sale | Finger Michael H. | director | 750 0.0509% | $5.75 | $4,313 | -18.29% | |
2025-02-18 | Sale | Finger Michael H. | director | 750 0.0453% | $5.00 | $3,750 | -11.09% | |
2023-06-28 | Warbington Timothy | President & CEO | 200 0.0014% | $4.36 | $872 | +3.85% | ||
2023-06-27 | Warbington Timothy | President & CEO | 800 0.0057% | $4.44 | $3,551 | +2.69% | ||
2022-11-22 | Warbington Timothy | President & CEO | 10,000 0.0712% | $0.39 | $3,897 | +28.28% | ||
2022-11-21 | Warbington Timothy | President & CEO | 15,000 0.1096% | $0.40 | $5,965 | +28.94% | ||
2022-09-27 | Warbington Timothy | President & CEO | 20,000 0.1403% | $0.50 | $10,000 | -1.58% | ||
2022-09-27 | Finger Michael H. | director | 2,000 0.014% | $0.50 | $1,000 | -1.58% | ||
2022-09-22 | Warbington Timothy | President & CEO | 12,000 0.0839% | $0.54 | $6,480 | -9.47% | ||
2022-09-21 | Warbington Timothy | President & CEO | 30,000 0.2172% | $0.61 | $18,337 | -17.17% | ||
2022-06-14 | Finger Michael H. | 10,000 0.111% | $0.70 | $7,000 | -18.57% | |||
2022-06-06 | Warbington Timothy | President & CEO | 8,000 0.0884% | $0.92 | $7,358 | -37.23% | ||
2022-05-20 | Finger Michael H. | 6,500 0.1061% | $1.50 | $9,750 | -41.18% | |||
2021-07-22 | Sale | Ichim Thomas | director | 1.45M 0.1167% | $0.03 | $43,645 | -84.06% | |
2021-07-21 | Sale | Ichim Thomas | director | 1.5M 0.1196% | $0.03 | $46,200 | -84.50% | |
2021-07-20 | Sale | Ichim Thomas | director | 1.4M 0.1123% | $0.03 | $42,560 | -84.14% | |
2017-08-29 | Sale | Warbington Timothy | CEO & President | 5,000 0.0047% | $0.20 | $1,000 | -91.75% | |
2017-08-29 | Sale | CREATIVE MEDICAL HEALTH INC. | 10 percent owner | 5,000 0.0047% | $0.20 | $1,000 | -91.75% | |
2017-06-05 | Sale | Warbington Timothy | President & CEO | 5,300 0.0051% | $0.30 | $1,615 | -96.88% | |
2017-06-05 | Sale | CREATIVE MEDICAL HEALTH INC. | 10 percent owner | 5,300 0.0051% | $0.30 | $1,615 | -96.88% |
Finger Michael H. | director | 351 0.0138% | $772.20 | 3 | 2 | |
CREATIVE MEDICAL HEALTH INC. | 10 percent owner | 58655927 2313.0221% | $129.04M | 1 | 6 | |
Herbst Timothy | 10 percent owner | 11346667 447.4414% | $24.96M | 1 | 0 | |
Ichim Thomas | director | 4529522 178.616% | $9.96M | 0 | 3 | |
Warbington Timothy | President & CEO | 12209 0.4814% | $26,859.80 | 9 | 6 | +3.27% |
$18,881,323 | 88 | -48.96% | $6.66M | |
$31,129 | 22 | -11.96% | $6.01M | |
$1,616,354 | 20 | -12.22% | $3.62M | |
$51,865 | 17 | -38.70% | $6.23M | |
$960,082 | 17 | -6.29% | $5.41M | |
$1,558,469 | 16 | -26.98% | $4.67M | |
$139,855 | 11 | -32.84% | $6.48M | |
$309,830 | 10 | -55.78% | $4.17M | |
$111,748 | 9 | -47.72% | $3.59M | |
$8,971,546 | 8 | 6.18% | $7.37M | |
$713,979 | 6 | -14.06% | $4.83M | |
$76,299 | 4 | 11.60% | $5.99M | |
$726,438 | 4 | -72.85% | $4.92M | |
$14,530 | 3 | 62.23% | $5.95M | |
$105,480 | 3 | -97.42% | $4.99M | |
$1,057,000 | 3 | 5.27% | $3.91M | |
Creative Medical Technology Holdings, Inc. (CELZ) | $4,423 | 2 | 3.27% | $5.58M |
$45,452 | 2 | -43.10% | $6.37M | |
$1,049,630 | 1 | -74.91% | $7.33M |
Increased Positions | 3 | +23.08% | 10,583 | +15.3% |
Decreased Positions | 5 | -38.46% | 49,909 | -72.14% |
New Positions | <1 | New | 10,308 | New |
Sold Out Positions | 3 | Sold Out | 47,176 | Sold Out |
Total Postitions | 11 | -15.38% | 29,860 | -56.84% |
Vanguard Group Inc | $51.00 | 0.88% | 17,629 | 0 | 0% | 2024-12-31 |
Geode Capital Management, Llc | $30.00 | 0.52% | 10,308 | +10,308 | New | 2024-12-31 |
Tower Research Capital Llc (Trc) | $5.00 | 0.08% | 1,648 | +245 | +17.46% | 2024-12-31 |
Osaic Holdings, Inc. | $0 | 0.01% | 131 | +30 | +29.7% | 2024-12-31 |
Bank Of America Corp /De/ | $0 | 0.01% | 122 | -9 | -6.87% | 2024-12-31 |
Morgan Stanley | $0 | <0.01% | 20 | 0 | 0% | 2024-12-31 |
Ubs Group Ag | $0 | 0% | 1 | -2,724 | -99.96% | 2024-12-31 |
Td Waterhouse Canada Inc. | $0 | 0% | 1 | 0 | 0% | 2024-12-31 |
Two Sigma Advisers, Lp | $0 | 0% | 0 | -14,500 | Sold Out | 2024-12-31 |
Aaron Wealth Advisors Llc | $0 | 0% | 0 | -19,570 | Sold Out | 2024-12-31 |